Determination of bisnafide, a novel bis-naphthalimide anticancer agent, in human plasma by high-performance liquid chromatography with UV detection

Journal of Pharmaceutical and Biomedical Analysis

Volumn 17, Issue 3, 1998, Pages 427-434

  Lai, Chii Ming ^a   Garner, Dennis M ^a   Gray, John E ^a   Brogdon, Bernice L ^a   Peterman, Vanessa C ^a   Pieniaszek Jr , Henry J ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Anticancer drug; Bis naphthalimide; Bisnafide; DMP 840; Human plasma; Quantitative determination; Reversed phase liquid chromatography

Indexed keywords

ANTINEOPLASTIC AGENT; BISNAFIDE MESYLATE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG DETERMINATION; EXTRACTION; HUMAN; PLASMA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTINEOPLASTIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; ISOQUINOLINES; MESYLATES; NEOPLASMS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS;

EID: 0032125992     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(97)00232-X     Document Type: Article

References (9)

1. [1] M.R. Kirshenbaum, S.F. Chen, C.H. Behrens, L.M. Papp, M.M. Stafford, J.H. Sun, D.L. Behrens, J.R. Fredericks, S.T. Polkus, P. Sipple, A.D. Patten, D. Dexter, S.P. Seitz, J.L. Gross, Cancer Res. 54 (1994) 2199-2206.
2. [2] M.M. Stafford, M.R. Kirshenbaum, K.J. Elliott, S.F. Chen, F. Perrella, T. Sun, G.L. Trainer, L.M. Papp, J.R. Fredericks, J.H. Sun, J.L. Gross, Proc. Am. Assoc. Cancer Res. 34 (1993) 384.
3. [3] R.J. McRipley, P.E. Burns-Horwitz, P.M. Czerniak, R.J. Diamond, M.A. Diamond, J.L.D. Miller, R.J. Page, D.L. Dexter, S.F. Chen, J.H. Sun, C.H. Behrens, S.P. Seitz, J.L. Gross, Cancer Res. 54 (1994) 159-164.
4. [4] P.W. Cobb, D.R. Degen, G.M. Clark, S.F. Chen, J.G. Kuhn, J.L. Gross, M.R. Kirshenbaum, J. H Sun, H.A. Burris III, D. Von Hoff, J. Natl. Cancer Inst. 86 (1994) 1462-1465.
5. [5] P. Cobb, H. Burris, M. Finizio, C. Lai, J. Eckardt, S. Fields, J. Kuhn, J. Nelson, K. Bunitsky, H. Pieniaszek, B. Brogdon, D. Von Hoff, Proc. Am. Soc. Clin. Oncol. 13 (1994) 159.
6. [6] J. Maroun, D. Stewart, R. Goel, G. Goss, S. Verma, J. Yau, M. Finizio, C. M. Lai, K. Bunitsky, H. Pieniaszek, B. Brogdon, Proc. Am. Soc. Clin. Oncol. 13 (1994) 151.
7. [7] W. Slichenmyer, M. Finizio, S. Sartorious, E. Rowinsky, C.M. Lai, L. Grochow, H. Pieniaszek, S. O'Reilly, K. Bunitsky, B. Brogdon, D. Mabrang, C. Shifflett, R. Donehower, Proc. Am. Soc. Clin. Oncol. 13 (1994) 142.
8. [8] H. Pieniaszek, C.M. Lai, W. Slichenmyer, J. Maroun, P. Cobb, A. Davidson, M. Finizio, B. Brogdon, K. Bunitsky, J.H. Sun, S. Sartorious, L. Grochow, D. Stewart, R. Goel, H. Burris, J. Eckardt, D. Nibbelink, C. Quon, D. Winslow, R. Donehower, D. Von Hoff, J. Clin. Pharmacol. 34 (1994) 1017.
9. [9] C. Pratt, B. Rao, C. Stewart, J. Jenkins, Urol. Oncol. 1 (1995) 166-167.